Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Conklin HM et al. - Methylphenidate is generally well tolerated by childhood cancer survivors. There is a subgroup at increased risk for side effects that may need to be closely monitored or prescribed a lower medication dose. The seemingly paradoxical findings of increased "side effects" at baseline must be considered when monitoring side effects and designing clinical trials.

Related Articles

Infiltrating glomus tumor of uncertain malignant potential arising in the kidney
Human Pathology, 11/12/09    Relevance Score: 94%

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Journal of Clinical Oncology, 10/30/09    Relevance Score: 93%

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09    Relevance Score: 92%

Collision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09    Relevance Score: 92%

Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
Journal of Cancer Research & Clinical Oncology, 10/01/09    Relevance Score: 92%

Today in Adverse Drug Reactions...keeping you current

Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09

Complications and side-effects of foam sclerotherapy
Phlebology, 12/09/09

Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address